مصطلحات الفهرس: controlled study, coronary artery disease/dt [Drug Therapy], coronary artery disease/rh [Rehabilitation], coronary artery disease/th [Therapy], drug use, female, follow up, healthy diet, healthy lifestyle, heart rehabilitation, human, lipid blood level, lipoprotein blood level, major clinical study, male, middle aged, non ST segment elevation myocardial infarction/rh [Rehabilitation], non ST segment elevation myocardial infarction/th [Therapy], percutaneous coronary intervention, physical activity, physical inactivity, aged, prediction, priority journal, prospective study, sex difference, smoking, ST segment elevation myocardial infarction/rh [Rehabilitation], ST segment elevation myocardial infarction/th [Therapy], stable angina pectoris/rh [Rehabilitation], stable angina pectoris/th [Therapy], triacylglycerol blood level, unstable angina pectoris/rh [Rehabilitation], unstable angina pectoris/th [Therapy], acetylsalicylic acid/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antithrombocytic agent/dt [Drug Therapy], cholesterol/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], high density lipoprotein/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], lipid/ec [Endogenous Compound], Australia, thienopyridine derivative/dt [Drug Therapy], ticagrelor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], adult, low density lipoprotein cholesterol/ec [Endogenous Compound], cholesterol blood level, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26999Test
Heart Lung and Circulation
Click here for full text options
LibKey Link

مصطلحات الفهرس: controlled study, coronary artery disease/dt [Drug Therapy], coronary artery disease/rh [Rehabilitation], coronary artery disease/th [Therapy], drug use, female, follow up, healthy diet, healthy lifestyle, heart rehabilitation, human, lipid blood level, lipoprotein blood level, major clinical study, male, middle aged, non ST segment elevation myocardial infarction/rh [Rehabilitation], non ST segment elevation myocardial infarction/th [Therapy], percutaneous coronary intervention, physical activity, physical inactivity, aged, prediction, priority journal, prospective study, sex difference, smoking, ST segment elevation myocardial infarction/rh [Rehabilitation], ST segment elevation myocardial infarction/th [Therapy], stable angina pectoris/rh [Rehabilitation], stable angina pectoris/th [Therapy], triacylglycerol blood level, unstable angina pectoris/rh [Rehabilitation], unstable angina pectoris/th [Therapy], acetylsalicylic acid/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antithrombocytic agent/dt [Drug Therapy], cholesterol/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], high density lipoprotein/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], lipid/ec [Endogenous Compound], Australia, thienopyridine derivative/dt [Drug Therapy], ticagrelor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], adult, low density lipoprotein cholesterol/ec [Endogenous Compound], cholesterol blood level, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26999Test
Heart Lung and Circulation
LibKey Link

مصطلحات الفهرس: effect size, follow up, human, intravascular ultrasound, meta analysis, priority journal, review, systematic review, therapy effect, ezetimibe/cb [Drug Combination], ezetimibe/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], low density lipoprotein cholesterol/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/cb [Drug Combination], cholesterol blood level, comparative study, coronary artery atherosclerosis/dt [Drug Therapy], atheroma, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37214Test
Journal of Clinical Lipidology
Click here for full text options
LibKey Link

مصطلحات الفهرس: effect size, follow up, human, intravascular ultrasound, meta analysis, priority journal, review, systematic review, therapy effect, ezetimibe/cb [Drug Combination], ezetimibe/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], low density lipoprotein cholesterol/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/cb [Drug Combination], cholesterol blood level, comparative study, coronary artery atherosclerosis/dt [Drug Therapy], atheroma, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/37214Test
Journal of Clinical Lipidology
Click here for full text options
LibKey Link

مصطلحات الفهرس: cognitive defect/si [Side Effect], confusion/si [Side Effect], congestive heart failure/si [Side Effect], coronary artery atherosclerosis/dt [Drug Therapy], demyelination/si [Side Effect], disorders of higher cerebral function/si [Side Effect], drug cost, drug research, familial hypercholesterolemia/dm [Disease Management], familial hypercholesterolemia/dt [Drug Therapy], fatigue/si [Side Effect], headache/si [Side Effect], heart infarction/si [Side Effect], heart muscle revascularization, human, hypercholesterolemia/dt [Drug Therapy], hyperlipidemia/dt [Drug Therapy], injection site reaction/si [Side Effect], ischemic heart disease/si [Side Effect], memory disorder/si [Side Effect], meta analysis (topic), monotherapy, multicenter study (topic), myalgia/si [Side Effect], neuritis/si [Side Effect], nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), priority journal, protein function, randomized controlled trial (topic), review, alirocumab/sc [Subcutaneous Drug Administration], aspartate aminotransferase/ec [Endogenous Compound], bococizumab/ct [Clinical Trial], bococizumab/cm [Drug Comparison], bococizumab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], evolocumab/ae [Adverse Drug Reaction], evolocumab/ct [Clinical Trial], evolocumab/cm [Drug Comparison], evolocumab/dt [Drug Therapy], ezetimibe/ct [Clinical Trial], ezetimibe/cm [Drug Comparison], ezetimibe/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/ae [Adverse Drug Reaction], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], monoclonal antibody/ct [Clinical Trial], monoclonal antibody/dt [Drug Therapy], placebo, proprotein convertase 9/ec [Endogenous Compound], unclassified drug, monoclonal antibody proprotein convertase 9/ct [Clinical Trial], monoclonal antibody proprotein convertase 9/dt [Drug Therapy], phase 1 clinical trial (topic), side effect/si [Side Effect], unstable angina pectoris/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], alirocumab/ae [Adverse Drug Reaction], alirocumab/ct [Clinical Trial], alirocumab/cm [Drug Comparison], alirocumab/dt [Drug Therapy], alirocumab/pe [Pharmacoeconomics], amnesia/si [Side Effect], arthralgia/si [Side Effect], ataxia/si [Side Effect], brain ischemia/si [Side Effect], cardiovascular disease/si [Side Effect], clinical effectiveness, clinical practice, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38660Test
Heart Lung and Circulation
Click here for full text options
LibKey Link

مصطلحات الفهرس: patient care, practice guideline, review, angiotensin receptor antagonist/dt [Drug Therapy], antilipemic agent, calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl peptidase IV inhibitor/cb [Drug Combination], dipeptidyl peptidase IV inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], glucagon like peptide 1 receptor agonist/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], insulin/dt [Drug Therapy], metformin/cb [Drug Combination], metformin/dt [Drug Therapy], nicotinic acid/dt [Drug Therapy], sodium glucose cotransporter 2 inhibitor/cb [Drug Combination], sodium glucose cotransporter 2 inhibitor/dt [Drug Therapy], sulfonylurea/cb [Drug Combination], sulfonylurea/dt [Drug Therapy], thiazide diuretic agent/dt [Drug Therapy], bile acid sequestrant/dt [Drug Therapy], add on therapy, cardiovascular disease/co [Complication], cardiovascular risk, clinical outcome, early diagnosis, female, high risk patient, human, hyperlipidemia/dt [Drug Therapy], hypertension/dt [Drug Therapy], non insulin dependent diabetes mellitus/di [Diagnosis], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], non insulin dependent diabetes mellitus/th [Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41520Test
Medicine Today
Click here for full text options
LibKey Link

مصطلحات الفهرس: patient care, practice guideline, review, angiotensin receptor antagonist/dt [Drug Therapy], antilipemic agent, calcium channel blocking agent/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl peptidase IV inhibitor/cb [Drug Combination], dipeptidyl peptidase IV inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], glucagon like peptide 1 receptor agonist/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], insulin/dt [Drug Therapy], metformin/cb [Drug Combination], metformin/dt [Drug Therapy], nicotinic acid/dt [Drug Therapy], sodium glucose cotransporter 2 inhibitor/cb [Drug Combination], sodium glucose cotransporter 2 inhibitor/dt [Drug Therapy], sulfonylurea/cb [Drug Combination], sulfonylurea/dt [Drug Therapy], thiazide diuretic agent/dt [Drug Therapy], bile acid sequestrant/dt [Drug Therapy], add on therapy, cardiovascular disease/co [Complication], cardiovascular risk, clinical outcome, early diagnosis, female, high risk patient, human, hyperlipidemia/dt [Drug Therapy], hypertension/dt [Drug Therapy], non insulin dependent diabetes mellitus/di [Diagnosis], non insulin dependent diabetes mellitus/dt [Drug Therapy], non insulin dependent diabetes mellitus/pc [Prevention], non insulin dependent diabetes mellitus/th [Therapy], Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/41520Test
Medicine Today
Click here for full text options
LibKey Link

مصطلحات الفهرس: cognitive defect/si [Side Effect], confusion/si [Side Effect], congestive heart failure/si [Side Effect], coronary artery atherosclerosis/dt [Drug Therapy], demyelination/si [Side Effect], disorders of higher cerebral function/si [Side Effect], drug cost, drug research, familial hypercholesterolemia/dm [Disease Management], familial hypercholesterolemia/dt [Drug Therapy], fatigue/si [Side Effect], headache/si [Side Effect], heart infarction/si [Side Effect], heart muscle revascularization, human, hypercholesterolemia/dt [Drug Therapy], hyperlipidemia/dt [Drug Therapy], injection site reaction/si [Side Effect], ischemic heart disease/si [Side Effect], memory disorder/si [Side Effect], meta analysis (topic), monotherapy, multicenter study (topic), myalgia/si [Side Effect], neuritis/si [Side Effect], nonhuman, phase 2 clinical trial (topic), phase 3 clinical trial (topic), priority journal, protein function, randomized controlled trial (topic), review, alirocumab/sc [Subcutaneous Drug Administration], aspartate aminotransferase/ec [Endogenous Compound], bococizumab/ct [Clinical Trial], bococizumab/cm [Drug Comparison], bococizumab/dt [Drug Therapy], creatinine/ec [Endogenous Compound], evolocumab/ae [Adverse Drug Reaction], evolocumab/ct [Clinical Trial], evolocumab/cm [Drug Comparison], evolocumab/dt [Drug Therapy], ezetimibe/ct [Clinical Trial], ezetimibe/cm [Drug Comparison], ezetimibe/dt [Drug Therapy], hydroxymethylglutaryl coenzyme A reductase inhibitor/ae [Adverse Drug Reaction], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], monoclonal antibody/ct [Clinical Trial], monoclonal antibody/dt [Drug Therapy], placebo, proprotein convertase 9/ec [Endogenous Compound], unclassified drug, monoclonal antibody proprotein convertase 9/ct [Clinical Trial], monoclonal antibody proprotein convertase 9/dt [Drug Therapy], phase 1 clinical trial (topic), side effect/si [Side Effect], unstable angina pectoris/si [Side Effect], alanine aminotransferase/ec [Endogenous Compound], alirocumab/ae [Adverse Drug Reaction], alirocumab/ct [Clinical Trial], alirocumab/cm [Drug Comparison], alirocumab/dt [Drug Therapy], alirocumab/pe [Pharmacoeconomics], amnesia/si [Side Effect], arthralgia/si [Side Effect], ataxia/si [Side Effect], brain ischemia/si [Side Effect], cardiovascular disease/si [Side Effect], clinical effectiveness, clinical practice, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38660Test
Heart Lung and Circulation
Click here for full text options
LibKey Link

مصطلحات الفهرس: body mass, clinical assessment, controlled study, drug dose increase, drug response, female, human, hypertriglyceridemia/dt [Drug Therapy], major clinical study, male, priority journal, ezetimibe/dt [Drug Therapy], fenofibrate/do [Drug Dose], fenofibrate/pd [Pharmacology], high density lipoprotein cholesterol/ec [Endogenous Compound], rosiglitazone/dt [Drug Therapy], simvastatin/dt [Drug Therapy], unclassified drug, supralip, atorvastatin/dt [Drug Therapy], adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31324Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: body mass, clinical assessment, controlled study, drug dose increase, drug response, female, human, hypertriglyceridemia/dt [Drug Therapy], major clinical study, male, priority journal, ezetimibe/dt [Drug Therapy], fenofibrate/do [Drug Dose], fenofibrate/pd [Pharmacology], high density lipoprotein cholesterol/ec [Endogenous Compound], rosiglitazone/dt [Drug Therapy], simvastatin/dt [Drug Therapy], unclassified drug, supralip, atorvastatin/dt [Drug Therapy], adult, article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31324Test
LibKey Link